Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates

Background: The impact of coronary artery disease (CAD) extension/complexity on outcomes and on the comparative benefits/risks of zotarolimus-eluting stent (ZES) versus bare-metal stents (BMS) remains unclear in patients at high risk of bleeding or thrombosis or at low restenosis risk.

Saved in:
Bibliographic Details
Main Authors: Gargiulo Giuseppe
Patialiakas Athanasios
Piccolo Raffaele
Thury Attila
Colangelo Salvatore
Campo Gianluca
Tebaldi Matteo
Ungi Imre
Tondi Stefano
Roffi Marco
Menozzi Alberto
de Cesare Nicoletta
Garbo Roberto
Meliga Emanuele
Testa Luca
Gabriel Henrique Mesquita
Ferlini Marco
Liistro Francesco
Dellavalle Antonio
Vranckx Pascal
Briguori Carlo
Windecker Stephan
Valgimigli Marco
Format: Article
Published: 2019
Series:INTERNATIONAL JOURNAL OF CARDIOLOGY 277
Subjects:
doi:10.1016/j.ijcard.2018.09.120

mtmt:30519182
Online Access:http://publicatio.bibl.u-szeged.hu/22345
Description
Summary:Background: The impact of coronary artery disease (CAD) extension/complexity on outcomes and on the comparative benefits/risks of zotarolimus-eluting stent (ZES) versus bare-metal stents (BMS) remains unclear in patients at high risk of bleeding or thrombosis or at low restenosis risk.
Physical Description:60-65
ISSN:0167-5273